| Others |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Writing and Speaking > What Do Today’s Pornographers & Book Publishers Have in Common? |
|
Others - What Do Today’s Pornographers & Book Publishers Have in Common?
This morning’s The New York Times features an article about how today's pornographers are experiencing a recession, perhaps the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product first of the electronic age. The Internet, with its zillions of amateur strippers, swappers, and sizzling sinners, is making ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in it harder for XXX video producers to turn a profit. They’re not alone. Traditional book publishers are also struggling. They lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. re competing against a tsunami of free content provided by amateur authors. Many surprisingly capable writers are uploading co here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ntent and diverting bookstore frequenters to their free wares. Ezinearticles.com, for example, is a site that hosts more than d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro 0,000 writers, all of them toiling gratis. Some of these scribes are submitting as many as 10,000 pieces, which is the equivale ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nt of 100 non-fiction books. Why are they, literally, giving away their work product? Several reasons: (1) They’ve been lock easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d out of the traditional publishing game. Without a track record and established credibility or a special audience, they simply nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically can’t get the attention of the brick and mortar community. (2) Some are established authors who find traditional publishers a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e becoming vanity or subsidy presses. If authors promise to purchase thousands of their own titles, to hawk at speaking and sem ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi inar events, then publishers will be eager to serve as glorified printing presses. If authors can’t minimize a publisher’s risk ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a in this way, they are often shunned. (3) There was never much money in the traditional publishing game for most authors. So, dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nstead of trying to hit the jackpot, they trade a few bucks, lots of marketing effort and humiliating rejections for a sure thi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ng—getting their texts in front of at least some readers, and doing so quickly. (4) Authors like to control their work product tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . They know their audiences better than most publishers, and they appreciate nixing the meddling intermediaries who insist on m t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel icromanaging titles, contents, and style. (5) Authors, especially experienced ones, know that most traditional publishers are ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lueless when it comes to predicting which books will sell. Famously, the “Chicken Soup” books were rejected over and again by “ y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the best and the brightest” acquisitions editors at big publishing houses before what was a tiny press, Health Communications, . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ade an offer. Most people aren’t going to weep over the losses suffered by pornographers. And most authors aren’t going to sh elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ed any tears for a traditional publishing community that has had its head in the sand for the better part of the past 200 years tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Entrepreneur Success Story-How Terry Hart Made $100,000 in 8 Months Starting With No Money Forex Trading - The Big Bucks Lurking In Booming Economies Patent, Trademark And Copyright - The Differences
|